Drug Development

Articles

The collaboration follows the signing of a cooperative research agreement between Sanofi Pasteur, Fiocruz, and WRAIR.

Sanofi Pasteur Collaborates with WRAIR, Fiocruz on Zika Vaccine Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

FDA’s new Office of Tissues and Advanced Therapies will oversee a growing range of cellular and genetic products.

FDA Tackles Cellular, Gene Therapies

Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.

Catalent Breaks Ground for Expanded Biologics Facility

Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.

Horizon Discovery Signs Subscription-Based Licensing Agreement for Biomanufacturing Cell Lines

Datwyler is channelling more than CHF 100 million into building a new plant in the US state of Delaware, which will be used to manufacture elastomer components for injectable drug-delivery systems.

Datwyler Invests in New US Plant

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

A new study proposes a new way to potentially treat congenital diseases in utero.

Study Demonstrates Potential Method for Treating Congenital Diseases In Utero

HHS entered into a contract with BioProtection Systems Corp. for commercial manufacturing tests of an Ebola vaccine.

HHS Sponsors Commercial Manufacturing Tests for Ebola Vaccine

WuXi AppTec’s new biomanufacturing facility is its third facility in the Philadelphia, PA Navy Yard.

WuXi AppTec Unveils Manufacturing Center for Cell and Gene Therapies

Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for direct compression.

Capsugel and Merck KGaA Named Winners of the Formulation and Excipients Category of the CPhI Pharma Awards

The Intelligent Control Inhaler is an intuitive, fully-integrated device delivering accurate doses of medication to patients, while providing on-screen instructions for use and feedback to the patient and healthcare provider via an app.

Formulation and Drug Delivery